|
|
Blood, 1 June 2005, Vol. 105, No. 11, pp. 4282-4289.
Prepublished online as a Blood First Edition Paper on February 17, 2005; DOI 10.1182/blood-2004-02-0756.
Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Identification and characterization of undifferentiated mast cells in mouse bone marrow
Maria Célia Jamur,
Ana Cristina G. Grodzki,
Elsa H. Berenstein,
Majed M. Hamawy,
Reuben P. Siraganian, and
Constance Oliver
From the Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto-Universidade de São Paulo, Ribeirão Preto, Brasil; and the Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD.
Sequential immunomagnetic isolation with 2 monoclonal antibodies was used to purify and characterize an undifferentiated mast cell in adult mouse bone marrow that had not been previously recognized. This cell represents 0.02% of the cells in the bone marrow, is CD34+, CD13+, and c-kit+, and does not express Fc RI. However, by polymerase chain reaction (PCR) the cell contains message for the and subunits of Fc RI, mast cellspecific proteases, and carboxypeptidase A. Morphologically, this cell has a large nucleus, little cytoplasm, few cytoplasmic organelles, and no cytoplasmic granules. In vitro, in the presence of interleukin-3 (IL-3) and stem cell factor (SCF) these cells differentiate only into a granulated mast cell that now expresses CD13, c-kit, mast cellspecific gangliosides, Fc RI, and binds immunoglobulin E (IgE). When injected into lethally irradiated mice, these cells are able to reconstitute the mast cell population in the spleen.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. L. Weller, S. J. Collington, A. Hartnell, D. M. Conroy, T. Kaise, J. E. Barker, M. S. Wilson, G. W. Taylor, P. J. Jose, and T. J. Williams
Chemotactic action of prostaglandin E2 on mouse mast cells acting via the PGE2 receptor 3
PNAS,
July 10, 2007;
104(28):
11712 - 11717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Waskow, S. Bartels, S. M. Schlenner, C. Costa, and H.-R. Rodewald
Kit is essential for PMA-inflammation-induced mast-cell accumulation in the skin
Blood,
June 15, 2007;
109(12):
5363 - 5370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Oliver, A. Fujimura, A. M. M. Silveira e Souza, R. Orlandini de Castro, R. P. Siraganian, and M. C. Jamur
Mast Cell-specific Gangliosides and Fc{varepsilon}RI Follow the Same Endocytic Pathway From Lipid Rafts in RBL-2H3 Cells
J. Histochem. Cytochem.,
April 1, 2007;
55(4):
315 - 325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Meindl, U. Schmidt, C. Vaculik, and A. Elbe-Burger
Characterization, isolation, and differentiation of murine skin cells expressing hematopoietic stem cell markers
J. Leukoc. Biol.,
October 1, 2006;
80(4):
816 - 826.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Arinobu, H. Iwasaki, M. F. Gurish, S.-i. Mizuno, H. Shigematsu, H. Ozawa, D. G. Tenen, K. F. Austen, and K. Akashi
Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis
PNAS,
December 13, 2005;
102(50):
18105 - 18110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Weller, S. J. Collington, J. K. Brown, H. R.P. Miller, A. Al-Kashi, P. Clark, P. J. Jose, A. Hartnell, and T. J. Williams
Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors
J. Exp. Med.,
June 20, 2005;
201(12):
1961 - 1971.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |